Accenture beat on sales and earnings this morning, but its guidance fell a nickel short. Bookings growth has also turned negative. At 26 times earnings, Accenture stock isn't the most expensive ...

Accenture (NYSE: ACN) stock fell 8% through 10 a.m. ET Thursday despite exceeding expectations in its earnings report for the fiscal second quarter of 2025. Analysts had forecast Accenture would ...

Hims & Hers Health (NYSE: HIMS) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target on the pharmaceuticals stock in the worst way possible. BofA added only ...

Bank of America raised its price target on Hims & Hers Health, but still thinks you should sell the stock. February saw a spike in weight loss sales at the drug compounder, but future sales of ...

This year’s trade show will be held at the Gold Coast Convention and Exhibition Centre from 6 to 7 April and is expected to build on the strong momentum generated at the previous show. After shifting ...